Efficacy of Serious Game Interventions on HCV Education for HIV Patients

NCT05497388 | Active Not Recruiting

• 1 other identifier: 202206084RIND
• Study Type: interventional
• Target: 162
• Locations: 1 country
• Sites: 1

Brief Summary

Hepatitis C transmission has a high rate of infection and re-infection among PLWH men who have sex with men (MSM), and co-infection increases liver and HIV morbidity. The MSM group has a low level of awareness and perception of hepatitis C, and lacks health beliefs and prevention behaviors about hepatitis C. In the absence of hepatitis C cognition and health belief, it should be possible to use the health belief model to intervene and design teaching programs to improve the effectiveness of hepatitis C prevention and treatment. In the past, hepatitis C prevention education mostly focused on people who inject drugs (PWID), and was taught in traditional teaching methods. However, the common cause of hepatitis C infection among drug addicts is the sharing of needles and equipment. Education is mainly based on drug harm reduction and prevention education, while the MSM group is infected with hepatitis C mainly through risky sexual behaviors. The hepatitis C prevention education of drug addicts is adopted The content is clearly not applicable to the MSM population. Due to the stigma of PLWH's MSM in the society, individual cases will be subject to prejudice, discrimination and unfair treatment, and they are worried about being excluded from outsiders. Therefore, it is necessary to provide a learning environment with a sense of privacy, security and respect. Serious Games is an educational game that provides a ubiquitous way of learning, using smartphones as a teaching tool, allowing learners to maintain a sense of privacy. Positive outcomes in cognitions, attitudes and behaviours related to health promotion and disease management. In terms of sexually transmitted diseases prevention measures, game content can be formulated for specific ethnic groups, and sensitive topics can be placed in the game. Without being exposed to real risks, players can simulate the consequences of various risks and corresponding prevention methods to prevent Motivate learners to solve problems and learn motivation, and give clear feedback, thereby increasing the knowledge of hepatitis C, health beliefs and the effectiveness of preventive self-efficacy.

Conditions

HIV Infections

Keywords

MSM; Hepatitis C; Health Belief Patterns; Serious Games

Outcome Measures

Primary Outcomes (1)

• The effect of "serious game-assisted teaching" intervention program on MSM.

  The changes of Questionnaire score of hepatitis C knowledge, health beliefs, and self-efficacy will be measured, Questionnaire including: 1. HCV Knowledge Scale:Scores range from 0 to 15, with higher scores representing higher knowledge of hepatitis C 2. Health Belief Model (HBM):Scores range from 1 to 28, with higher scores representing more positive hepatitis C prevention beliefs. 3. Self-Efficacy Scale:Scores range from 1 to 8, with higher scores representing better self-efficacy.

  12 weeks after intervention.

Study Arms (2)

Web for HCV education

NO INTERVENTION

Serious Game for HCV education

EXPERIMENTAL

Other: Serious Game

Interventions

Serious Game OTHER

using Serious Game for HCV education

Serious Game for HCV education

Eligibility Criteria

• Age: 20 Years - 45 Years
• Sex: male
• Healthy Volunteers: No
• Age Groups: Adult (18-64)

You may qualify if:

• HIV-infected men who have sex with men aged 20-45
• Can communicate in appropriate language and understand the research content
• Able to use smartphone products

You may not qualify if:

• Unable to fully participate in this study

Sponsors & Collaborators

• National Taiwan University Hospital: lead

Study Sites (1)

Yi Ting Chen

Taipei, 100, Taiwan

Location

MeSH Terms

Conditions

HIV Infections; Hepatitis C

Condition Hierarchy (Ancestors)

Blood-Borne Infections; Communicable Diseases; Infections; Sexually Transmitted Diseases, Viral; Sexually Transmitted Diseases; Lentivirus Infections; Retroviridae Infections; RNA Virus Infections; Virus Diseases; Genital Diseases; Urogenital Diseases; Immunologic Deficiency Syndromes; Immune System Diseases; Hepatitis, Viral, Human; Flaviviridae Infections; Hepatitis; Liver Diseases; Digestive System Diseases

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Purpose: PREVENTION
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: July 28, 2022
• First Posted: August 11, 2022
• Study Start: February 23, 2023
• Primary Completion: July 31, 2024
• Study Completion: December 31, 2024
• Last Updated: October 18, 2024

Record last verified: 2024-10

Data Sharing

• IPD Sharing: Will not share

Locations

TW (1)